Cargando…

1664. The Impact of Levofloxacin Prophylaxis on Empiric Intravenous Antibiotic Use in Pediatric Hematopoietic Stem Cell Transplant Recipients

BACKGROUND: Clinical trials have demonstrated that levofloxacin prophylaxis during periods of neutropenia in hematopoietic stem cell transplantation (HSCT) reduces the frequency of bacteremia in adults and febrile episodes in children. Therefore, levofloxacin prophylaxis may also have a role in redu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prodanuk, Michael, Timberlake, Kathryn E, Koo, Alicia, Chopra, Yogi, Wall, Donna, Science, Michelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677974/ http://dx.doi.org/10.1093/ofid/ofad500.1497

Ejemplares similares

Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital
por: Kimura, Muneyoshi, et al.
Publicado: (2016)

Reduction in Obesity-Related Hepatic Fibrosis by SR1664
por: McVicker, Benita L., et al.
Publicado: (2023)

Prophylaxis with levofloxacin: impact on bacterial susceptibility and epidemiology in a hematopoietic stem cell transplant unit
por: Lopes, Livia Amaral Alonso, et al.
Publicado: (2014)

Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients
por: Guimarães, Thaís, et al.
Publicado: (2022)

P1664: WHICH FACTORS DO IMPACT IN OPTIMAL ANTICOAGULATION IN ANTIPHOSPHOLIPID SYNDROME?
por: Ontiveros-Austria, Juan Luis, et al.
Publicado: (2023)

1664. Maternal Hookworm Infection and Its Effect on Maternal/Child Health: A Systematic Review and Meta-Analysis
por: Ness, Tara, et al.
Publicado: (2019)

194. Antibiotic-resistant bloodstream infections in pediatric oncology patients on levofloxacin prophylaxis
por: Sridhar, Sunita, et al.
Publicado: (2020)

Levofloxacin Versus Ciprofloxacin-Based Prophylaxis during the Pre-Engraftment Phase in Allogeneic Hematopoietic Stem Cell Transplant Pediatric Recipients: A Single-Center Retrospective Matched Analysis
por: Servidio, Alessia G., et al.
Publicado: (2021)

1664 Case Series of Imported Enteric Fever in Japan: Clinical Characteristics, Antibiotics Susceptibility, and Relapse Risk Factors
por: Matono, Takashi, et al.
Publicado: (2014)

1664. The Utilization of Hospital Inpatient Care due to Tuberculosis, Republic of Ireland, 2015-2018
por: O’Connell, James A, et al.
Publicado: (2020)

269. De-Labeling of Allergies to Β-Lactam Antibiotics (De-LABeL) Program: Development and Pilot of an Inpatient Pediatric Program
por: Wong, Jacqueline, et al.
Publicado: (2018)

Prophylaxis with levofloxacin: bacterial infections and antimicrobial resistance in hematological malignancies
por: Campos, Claudio Penido
Publicado: (2014)

Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients
por: Lehrnbecher, Thomas, et al.
Publicado: (2020)

1591. Infectious Outcomes of Levofloxacin Prophylaxis in Obese vs. Non-obese Patients with Hematologic Malignancies
por: Kurtti, Amanda, et al.
Publicado: (2018)

Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB
por: Clerici, Daniela, et al.
Publicado: (2022)

Antibiotic Prescription Practice for Pediatric Urinary Tract Infection in a Tertiary Center
por: Alghounaim, Mohammad, et al.
Publicado: (2017)

Disposition Kinetics of Levofloxacin in Sheep after Intravenous and Intramuscular Administration
por: Goudah, Ayman, et al.
Publicado: (2010)

Single Dose of Levofloxacin versus Three Dosages for Prophylaxis in Prostate Biopsy
por: Linden-Castro, Edgar, et al.
Publicado: (2014)

De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia
por: Rearigh, Lindsey, et al.
Publicado: (2020)

Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis
por: De Rosa, Francesco Giuseppe, et al.
Publicado: (2013)

Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients With Hematologic Malignancy
por: Ziegler, Matthew, et al.
Publicado: (2019)

Population pharmacokinetics and dose optimization of intravenous levofloxacin in hospitalized adult patients
por: Setiawan, Eko, et al.
Publicado: (2022)

Levofloxacin for the treatment of severe refractory BK virus-associated hemorrhagic cystitis in hematopoietic stem cell transplantation recipients: A report of three cases
por: TOPTAS, TAYFUR, et al.
Publicado: (2014)

Evaluation of the Empiric use of Levofloxacin in Combination with Antipseudomonal Β-Lactams for the Treatment of Pneumonia
por: Bachna, Jon, et al.
Publicado: (2017)

A Family of Early English Oculists (1600-1751), With a Reappraisal of John Thomas Woolhouse (1664-1733/1734)
por: Leffler, Christopher T, et al.
Publicado: (2017)

P1664: IMPACT OF A PROTOCOL USING RITUXIMAB FOR PREVENTION OF RELAPSE IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP)
por: Marín Sánchez, E., et al.
Publicado: (2022)

Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: A systematic review of randomized trials
por: Egan, Grace, et al.
Publicado: (2019)

Levofloxacin Prophylaxis Versus no Prophylaxis in Acute Myeloid Leukemia During Post-Induction Aplasia: a Single Center Study
por: Urbino, Irene, et al.
Publicado: (2023)

1581. Impact of Colonization with Fluoroquinolone-Resistant Enterobacteriaceae on the Risk of Gram-Negative Bacteremia in Hematopoietic Stem Cell Transplant Recipients Who Receive Prophylactic Levofloxacin
por: Satlin, Michael J, et al.
Publicado: (2018)

1595. Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients with Hematologic Malignancy
por: Ziegler, Matthew, et al.
Publicado: (2018)

Low-Dose Acyclovir Prophylaxis for Varicella zoster Reactivation in Autologous Hematopoietic Cell Transplantation Recipients
por: Fei, Naomi, et al.
Publicado: (2019)

Bacteremia in Hematopoietic Stem Cell Recipients Receiving Fluoroquinolone Prophylaxis: Incidence, Resistance, and Risk Factors
por: Eryilmaz-Eren, Esma, et al.
Publicado: (2022)

CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients
por: Chavaz, Lara, et al.
Publicado: (2023)

1353. Pediatric Urinary Tract Infections: A Choosing Wisely Initiative to Advance Antimicrobial Stewardship and Diagnostic Accuracy in the Emergency Department
por: Prodanuk, Michael, et al.
Publicado: (2020)

270. Prevalence and Impact of β-Lactam Allergies at a Canadian Pediatric Center
por: Wong, Jacqueline, et al.
Publicado: (2018)

Breakthrough Bacteremia with Meropenem-resistant Pseudomonas aeruginosa in Hematologic Malignancy Patients Receiving Levofloxacin Prophylaxis
por: Hakki, Morgan, et al.
Publicado: (2017)

Pharmacokinetic profiles of levofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits (Oryctolagus cuniculus)
por: Sitovs, Andrejs, et al.
Publicado: (2020)

Levofloxacin: Insights Into Antibiotic Resistance and Product Quality
por: Izadi, Ensieh, et al.
Publicado: (2019)

580. Refractory and Resistant CMV Infections in Hematopoietic Cell Transplant Recipients in the Letermovir Primary Prophylaxis Era
por: Sassine, Joseph, et al.
Publicado: (2020)

1291. Safety of Isavuconazole Compared with Voriconazole as Primary Antifungal Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients
por: Bogler, Yael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ku9bb7dpi5br6h8tsmdtje2avc